Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors Proactive dietary ...
This study examined the nursing diagnosis of inadequate nutritional intake in children with cancer. Despite its low prevalence (7.25%), findings confirm that this is a real and complex health issue in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback